Form D · Retailing
Global Immune Technologies Inc.
Missoula, MT · CIK 0001105284
Offering snapshot reported Nov 5, 2012 · SEC filing
- Reported sold
- $108K Indefinite offering
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jun 1, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2012 | Initial | $108,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-186488
Source: Form D, filed Nov 5, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey R Bruhjell | Director, Executive |
| Serge Talon | Director, Executive |
Issuer details
Industry: Retailing (See others in industry)
Address:
2809 Great Northern Loop Suite 100
Missoula, MT, 59808-1749
Missoula, MT, 59808-1749